Research and innovation into the development of novel therapeutics and ways of detecting diseases, as well as on how to improve the practice of pharmacy, is central to the activities of the School of Pharmacy and Biomolecular Sciences at RCSI.
Our staff conduct cutting-edge research on multiple disease areas of profound clinical importance, including cancers, neurodegenerative disorders, infectious diseases, haematological and immunological disorders, all with a view towards identifying novel therapeutic targets.
Our research impact
We conduct our research in a number of key areas with international and national collaborators from industry, hospitals and other universities and research institutes in order to improve the health of individuals and of populations.
Increasing our understanding of the diagnosis, transmission and management of a wide number of pathogens.
Developing safer and more effective treatments via collaborative research across a range of neurological conditions.